Work

Bayesian interim analysis and efficiency of phase III randomized trials

Year: 2025

Type: article

Source: British Journal of Cancer

DOI: 10.1038/s41416-025-03156-5

Authors: Alexander D. Sherry, Pavlos Msaouel, Avital M. Miller, Timothy A. Lin, Gabrielle S. Kupferman, Joseph Abi Jaoude, Ramez Kouzy, Molly B. El-Alam, Roshal Patel, Alex Koong, Christine Lin, Tomer Meirson, Zachary R. McCaw, Ethan B. Ludmir

Institutions: Mayo Clinic, The University of Texas MD Anderson Cancer Center, Stanford Medicine, Stanford University, Memorial Sloan Kettering Cancer Center, Rabin Medical Center, University of North Carolina at Chapel Hill, insitro, inc. (United States)

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Gateway for Cancer Research, Bristol-Myers Squibb, Pfizer, Exelixis, Andrew Sabin Family Foundation, Mirati Therapeutics, University of Texas MD Anderson Cancer Center, National Cancer Institute

Awards: G111615301, G293715275, Cancer Center Support Grant

OpenAlex ID: W4413107873

FWCI: 0.841

Cites: 54

Cited by: 1

Related to: 10